BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240226T080000
DTEND;TZID=UTC:20240228T170000
DTSTAMP:20230922T013152Z
CREATED:20230922T012759Z
LAST-MODIFIED:20230922T013152Z
UID:4655-1708934400-1709139600@thebiocalendar.com
SUMMARY:Speaker Programs Summit 2024
DESCRIPTION:The Speaker Programs Summit is the life sciences industry’s only educational forum focused on critical marketing\, operations and compliance matters for sustaining speaker programs. Gain valuable insights from HCPs\, as well as updates in the process of compliantly conducting speaker programs. Readers can receive a 10% discount on their registration with code 24B4B10.
URL:https://thebiocalendar.com/event/speaker-programs-summit-2024/
LOCATION:CA
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2023/09/SpeakerPrograms_600x200_Big4Bio.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240227
DTEND;VALUE=DATE:20240301
DTSTAMP:20240221T061911Z
CREATED:20240221T060323Z
LAST-MODIFIED:20240221T061911Z
UID:5308-1708992000-1709251199@thebiocalendar.com
SUMMARY:Immuno-Oncology 360°
DESCRIPTION:10th Annual:\n​​​​​​​Reporting on the Latest Advancements and Data in IO \n\n\n\n\nImmuno-Oncology 360° offers an unparalleled opportunity to hear from stakeholders representing both the science and business communities who report on the latest data impacting ​​​​​​​​​​​​​​IO to fight a wider range of cancers. \n\n\nIO360° Delivers 3 Key Benefits: \n\n\n\n\n1. Access to KOLs and stakeholders in the science and business communities\, reporting on cutting-edge research and trends shaping IO technology\, investment\, and innovation \n2. Presentations featuring 100+ talks on the latest innovative research delivered by international leaders from academia\, investors\, and industry representatives\n​​​​​​​\n3. 10+ hours of networking and business development opportunities to connect with 600+ attendees who specialize in cancer immunotherapy
URL:https://thebiocalendar.com/event/immuno-oncology-360-2/
LOCATION:CA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240228T110000
DTEND;TZID=UTC:20240228T121500
DTSTAMP:20240207T214007Z
CREATED:20240207T214007Z
LAST-MODIFIED:20240207T214007Z
UID:5265-1709118000-1709122500@thebiocalendar.com
SUMMARY:2024: What's On the Horizon
DESCRIPTION:We’ll discuss the investment and deal-making climate as well as the challenges the industry faces. The session will be moderated by Karen Carey\, Managing Editor\, BioWorld. \nDate: Wednesday\, February 28th\, 2024   \nTime: 11:00AM-12:15PM (ET)\, including Q&A \nMODERATOR: \nKaren Casey\, Managing Editor\, BioWorld \nSPEAKERS: \nRachelle Jacques\, President & CEO\, Akari Therapeutics \nTim Opler\, Managing Director\, Global Healthcare Group\, Stifel \nPeter Rubin\, Executive Director\, No Patient Left Behind (NPLB) \nDavid Jenkins\, Vice President\, Head of Research & External Innovation\, Ipsen
URL:https://thebiocalendar.com/event/2024-whats-on-the-horizon/
LOCATION:Online webinar
END:VEVENT
END:VCALENDAR